| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,139 | 25,420 | 24,432 | 27,280 | | Cost of Revenue | 9,069 | 9,956 | 10,269 | 10,423 | | | Gross Profit | 14,070 | 15,464 | 14,163 | 16,857 | | | Operating Expenses | | Research Development | 1,340 | 1,929 | 1,979 | 1,879 | | Selling General and Administrative | 14,560 | 15,298 | 14,321 | 15,502 | | Non Recurring | 233 | 525 | 14,658 | 2,602 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,063) | (2,288) | (16,795) | (3,126) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 217 | (22) | 108 | 1,057 | | Earnings Before Interest And Taxes | (1,846) | (2,310) | (16,687) | (2,069) | | Interest Expense | 102 | 137 | 140 | 755 | | Income Before Tax | (1,948) | (2,447) | (16,827) | (2,824) | | Income Tax Expense | 114 | 180 | 96 | 383 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,062) | (2,627) | (16,923) | (3,207) | | | Non-recurring Events | | Discontinued Operations | (2) | 35 | (45) | (180) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,064) | (2,592) | (16,968) | (3,387) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,064) | ($2,592) | ($16,968) | ($3,387) |
|
0.20% Nasdaq 
0.03 (3.75%) 
Income Statement
